These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 27074657

  • 1. Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.
    Broberg E, Melidou A, Prosenc K, Bragstad K, Hungnes O, WHO European Region and the European Influenza Surveillance Network members of the reporting countries.
    Euro Surveill; 2016; 21(13):. PubMed ID: 27074657
    [Abstract] [Full Text] [Related]

  • 2. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay J, Fonseca K, Charest H, Krajden M, Petric M, Mahmud SM, Van Caeseele P, Bastien N, Eshaghi A, Li Y.
    J Infect Dis; 2015 Sep 01; 212(5):726-39. PubMed ID: 25784728
    [Abstract] [Full Text] [Related]

  • 3. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J, Guglieri-López B, Tortajada-Girbés M, López-Labrador FX, Carballido-Fernández M, Mollar-Maseres J, Schwarz-Chavarri G, Baselga-Moreno V, Mira-Iglesias A, Díez-Domingo J, Valencia Hospital Network for the Study of Influenza, Respiratory Viruses Disease.
    Vaccine; 2017 Dec 19; 35(52):7331-7338. PubMed ID: 29128380
    [Abstract] [Full Text] [Related]

  • 4. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Martineau C, Charest H, Krajden M, Bastien N, Li Y.
    J Infect Dis; 2017 Dec 19; 216(12):1487-1500. PubMed ID: 29029166
    [Abstract] [Full Text] [Related]

  • 5. [Influenza surveillance in five consecutive seasons during post pandemic period: results from National Influenza Center, Turkey].
    Altaş AB, Bayrakdar F, Korukluoğlu G.
    Mikrobiyol Bul; 2016 Jul 19; 50(3):401-17. PubMed ID: 27525396
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N, McMenamin J, Durnall H, Ellis J, Lackenby A, Robertson C, von Wissmann B, Cottrell S, Smyth B, Moore C, Gunson R, Zambon M, Fleming D, Pebody R.
    Euro Surveill; 2014 Jul 10; 19(27):5-13. PubMed ID: 25033051
    [Abstract] [Full Text] [Related]

  • 7. Antigenic and genomic characterization of human influenza A and B viruses circulating in Argentina after the introduction of influenza A(H1N1)pdm09.
    Russo ML, Pontoriero AV, Benedetti E, Czech A, Avaro M, Periolo N, Campos AM, Savy VL, Baumeister EG.
    J Med Microbiol; 2014 Dec 10; 63(Pt 12):1626-1637. PubMed ID: 25351708
    [Abstract] [Full Text] [Related]

  • 8. Co-circulation of seasonal influenza A(H1N1)pdm09, A(H3N2) and B/Victoria lineage viruses with further genetic diversification, EU/EEA, 2022/23 influenza season.
    Broberg EK, Svartström O, Riess M, Kraus A, Vukovikj M, Melidou A, Members of the European Reference Laboratory Network for Human Influenza (ERLI-Net)Members of the ERLI-Net that contributed virus characterisation data or were involved in weekly surveillance activities are listed under Collaborators and at the end of the article., Collaborators.
    Euro Surveill; 2024 Sep 10; 29(39):. PubMed ID: 39328158
    [Abstract] [Full Text] [Related]

  • 9. Predominance of influenza A(H3N2) viruses during the 2016/2017 season in Bulgaria.
    Korsun N, Angelova S, Trifonova I, Tzotcheva I, Mileva S, Voleva S, Georgieva I, Perenovska P.
    J Med Microbiol; 2018 Feb 10; 67(2):228-239. PubMed ID: 29297852
    [Abstract] [Full Text] [Related]

  • 10. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y.
    J Infect Dis; 2009 Jan 15; 199(2):168-79. PubMed ID: 19086914
    [Abstract] [Full Text] [Related]

  • 11. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, Rogalska J, Pitigoi D, Paradowska-Stankiewicz I, Reuss A, Jiménez-Jorge S, Daviaud I, Guiomar R, O'Donnell J, Necula G, Głuchowska M, Moren A.
    Euro Surveill; 2014 Feb 13; 19(6):. PubMed ID: 24556348
    [Abstract] [Full Text] [Related]

  • 12. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
    Kissling E, Valenciano M, Pozo F, Vilcu AM, Reuss A, Rizzo C, Larrauri A, Horváth JK, Brytting M, Domegan L, Korczyńska M, Meijer A, Machado A, Ivanciuc A, Višekruna Vučina V, van der Werf S, Schweiger B, Bella A, Gherasim A, Ferenczi A, Zakikhany K, O Donnell J, Paradowska-Stankiewicz I, Dijkstra F, Guiomar R, Lazar M, Kurečić Filipović S, Johansen K, Moren A, I-MOVE/I-MOVE+ study team.
    Influenza Other Respir Viruses; 2018 Jul 13; 12(4):423-437. PubMed ID: 29125681
    [Abstract] [Full Text] [Related]

  • 13. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M.
    J Infect Dis; 2014 Jul 01; 210(1):126-37. PubMed ID: 24446529
    [Abstract] [Full Text] [Related]

  • 14. Influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2015.
    Leung VK, Spirason N, Lau H, Buettner I, Leang SK, Chow MK.
    Commun Dis Intell Q Rep; 2017 Jun 30; 41(2):E150-E160. PubMed ID: 28899310
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horváth JK, Domegan L, Pitigoi D, Machado A, Paradowska-Stankiewicz IA, Bella A, Larrauri A, Ferenczi A, Joan O´Donell, Lazar M, Pechirra P, Korczyńska MR, Pozo F, Moren A, I-MOVE multicentre case-control team.
    Euro Surveill; 2016 Jun 30; 21(7):pii=30139. PubMed ID: 26924024
    [Abstract] [Full Text] [Related]

  • 18. Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.
    Tivane A, Daniels R, Nguenha N, Machalele L, Nacoto A, Pale M, Mateonane E, Mavale S, Chilundo J, Muteto D, Salência J, Albati F, Gudo E, Mussá T, McCauley J.
    PLoS One; 2018 Jun 30; 13(7):e0201248. PubMed ID: 30048502
    [Abstract] [Full Text] [Related]

  • 19. Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
    Melidou A, Hungnes O, Pereyaslov D, Adlhoch C, Segaloff H, Robesyn E, Penttinen P, Olsen SJ, European Region influenza surveillance network.
    Vaccine; 2020 Jul 31; 38(35):5707-5717. PubMed ID: 32624252
    [Abstract] [Full Text] [Related]

  • 20. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.
    Chambers C, Skowronski DM, Sabaiduc S, Winter AL, Dickinson JA, De Serres G, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Krajden M, Bastien N, Li Y.
    Euro Surveill; 2016 Jul 31; 21(11):30168. PubMed ID: 27020673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.